Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J W Jukema

Showing results (111-120 of 225) with videos related to

Pageof 23
Sort By:
Arteriosclerosis, Thrombosis, and Vascular Biology|March 1, 1996
Evidence for a synergistic effect of calcium channel blockers with lipid-lowering therapy in retarding progression of coronary atherosclerosis in symptomatic patients with normal to moderately raised cholesterol levels. The REGRESS Study GroupJ W Jukema, A H Zwinderman, A J van Boven, et al.
European Radiology|January 8, 2022
Utilizing (serial) coronary computed tomography angiography (CCTA) to predict plaque progression and major adverse cardiac events (MACE): results, merits and challengesF Y van Driest, C M Bijns, R J van der Geest, et al.
International Journal of Cardiology|July 5, 2017
Chronic use of low-dose aspirin is not associated with lower bone mineral density in the general populationT N Bonten, R de Mutsert, F R Rosendaal, et al.
Heart (British Cardiac Society)|October 17, 2001
Pravastatin and endothelium dependent vasomotion after coronary angioplasty: the PREFACE trialH J Mulder, M J Schalij, B Kauer, et al.
European Journal of Radiology Open|April 11, 2022
Correlation between quantification of myocardial area at risk and ischemic burden at cardiac computed tomographyF Y van Driest, C M Bijns, R J van der Geest, et al.
International Journal of Cardiology|April 6, 2007
Dexamethasone-eluting stents for the prevention of in-stent restenosis: evidence for a differential effect in insulin-dependent and non-insulin-dependent diabetic patientsB L van der Hoeven, N M M Pires, H M Warda, et al.
Journal of Internal Medicine|August 3, 2006
Lipoprotein (a) and risk of cardiovascular disease in patients with metabolic syndrome in a population of familial hypercholesterolaemiaJ S Rana, A C Jansen, A H Zwinderman, et al.
The International Journal of Cardiovascular Imaging|June 23, 2021
Quantification of myocardial ischemia and subtended myocardial mass at adenosine stress cardiac computed tomography: a feasibility studyF Y van Driest, R J van der Geest, A Broersen, et al.
British Journal of Pharmacology|February 18, 2009
The dual PPARalpha/gamma agonist tesaglitazar blocks progression of pre-existing atherosclerosis in APOE*3Leiden.CETP transgenic miceJ W A van der Hoorn, J W Jukema, L M Havekes, et al.
International Journal of Cardiology|March 27, 2019
Corrigendum to "Dexamethasone-eluting stents for the prevention of in-stent restenosis: Evidence for a differential effect in insulin-dependent and non-insulin-dependent diabetic patients" [Int. J. Cardiol. 124 (2008) 166-171]B L van der Hoeven, N M M Pires, H M Warda, et al.
Pageof 23

Showing results (111-120 of 225) with videos related to

Sort By:
Pageof 23
Arteriosclerosis, Thrombosis, and Vascular Biology|March 1, 1996
Evidence for a synergistic effect of calcium channel blockers with lipid-lowering therapy in retarding progression of coronary atherosclerosis in symptomatic patients with normal to moderately raised cholesterol levels. The REGRESS Study GroupJ W Jukema, A H Zwinderman, A J van Boven, et al.
European Radiology|January 8, 2022
Utilizing (serial) coronary computed tomography angiography (CCTA) to predict plaque progression and major adverse cardiac events (MACE): results, merits and challengesF Y van Driest, C M Bijns, R J van der Geest, et al.
International Journal of Cardiology|July 5, 2017
Chronic use of low-dose aspirin is not associated with lower bone mineral density in the general populationT N Bonten, R de Mutsert, F R Rosendaal, et al.
Heart (British Cardiac Society)|October 17, 2001
Pravastatin and endothelium dependent vasomotion after coronary angioplasty: the PREFACE trialH J Mulder, M J Schalij, B Kauer, et al.
European Journal of Radiology Open|April 11, 2022
Correlation between quantification of myocardial area at risk and ischemic burden at cardiac computed tomographyF Y van Driest, C M Bijns, R J van der Geest, et al.
International Journal of Cardiology|April 6, 2007
Dexamethasone-eluting stents for the prevention of in-stent restenosis: evidence for a differential effect in insulin-dependent and non-insulin-dependent diabetic patientsB L van der Hoeven, N M M Pires, H M Warda, et al.
Journal of Internal Medicine|August 3, 2006
Lipoprotein (a) and risk of cardiovascular disease in patients with metabolic syndrome in a population of familial hypercholesterolaemiaJ S Rana, A C Jansen, A H Zwinderman, et al.
The International Journal of Cardiovascular Imaging|June 23, 2021
Quantification of myocardial ischemia and subtended myocardial mass at adenosine stress cardiac computed tomography: a feasibility studyF Y van Driest, R J van der Geest, A Broersen, et al.
British Journal of Pharmacology|February 18, 2009
The dual PPARalpha/gamma agonist tesaglitazar blocks progression of pre-existing atherosclerosis in APOE*3Leiden.CETP transgenic miceJ W A van der Hoorn, J W Jukema, L M Havekes, et al.
International Journal of Cardiology|March 27, 2019
Corrigendum to "Dexamethasone-eluting stents for the prevention of in-stent restenosis: Evidence for a differential effect in insulin-dependent and non-insulin-dependent diabetic patients" [Int. J. Cardiol. 124 (2008) 166-171]B L van der Hoeven, N M M Pires, H M Warda, et al.
Pageof 23